< Back to previous page

Publication

Updated Follow-up and Results of Subsequent Therapy in the Phase III VISTA Trial: Bortezomib Plus Melphalan-Prednisone Versus Melphalan-Prednisone in Newly Diagnosed Multiple Myeloma

Journal Contribution - Journal Article Conference Contribution

meeting abstract
Journal: Blood
ISSN: 0006-4971
Issue: 11
Volume: 112
Pages: 242-242
Keywords:multiple myeloma